Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine

02/02/2021

FILE PHOTO: The Pfizer logo is pictured outside a Pfizer office amid the coronavirus disease (COVID-19) outbreak in Brussels, Belgium January 21, 2021. REUTERS/Yves Herman/File Photo GLOBAL BUSINESS WEEK AHEAD

(Reuters) – Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.

The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.

Source: Read Full Article

Airtel hikes tariffs, family postpaid plan spiked for new customers

Ng Yu Zhi back in court, faces 18 new charges over billion-dollar nickel trading scheme that involved high profile investors

UK Jobless Rate Drops; Job Vacancies At New Record High